Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Chemical synthesis of 4-azido-β-galactosamine derivatives for inhibitors of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase.

Hor S, Kodama T, Sugiura N, Kondou H, Yanagida M, Yanagisawa K, Shibasawa A, Tsuzuki B, Fukatsu N, Nagao K, Yamana K, Hidari KIPJ, Watanabe H, Habuchi O, Nakano H.

Glycoconj J. 2018 Oct;35(5):477-491. doi: 10.1007/s10719-018-9839-2. Epub 2018 Sep 1.

PMID:
30173355
2.

Chemoenzymatic synthesis and characterization of N-glycolylneuraminic acid-carrying sialoglycopolypeptides as effective inhibitors against equine influenza virus hemagglutination.

Ogata M, Koizumi A, Otsubo T, Ikeda K, Sakamoto M, Aita R, Kato T, Park EY, Yamanaka T, Hidari KIPJ.

Biosci Biotechnol Biochem. 2017 Aug;81(8):1520-1528. doi: 10.1080/09168451.2017.1325315. Epub 2017 May 18.

PMID:
28521605
3.

Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E.

Watanabe I, Hikita T, Mizuno H, Sekita R, Minami A, Ishii A, Minamisawa Y, Suzuki K, Maeda H, Hidari KI, Suzuki T.

Glycobiology. 2015 Sep;25(9):953-62. doi: 10.1093/glycob/cwv039. Epub 2015 Jun 2.

PMID:
26036195
4.

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.

Yoneyama T, Ohyama C, Hatakeyama S, Narita S, Habuchi T, Koie T, Mori K, Hidari KI, Yamaguchi M, Suzuki T, Tobisawa Y.

Biochem Biophys Res Commun. 2014 Jun 13;448(4):390-6. doi: 10.1016/j.bbrc.2014.04.107. Epub 2014 May 9.

PMID:
24814705
5.

Computational design of a sulfoglucuronide derivative fitting into a hydrophobic pocket of dengue virus E protein.

Abe T, Sando A, Teraoka F, Otsubo T, Morita K, Tokiwa H, Ikeda K, Suzuki T, Hidari KI.

Biochem Biophys Res Commun. 2014 Jun 20;449(1):32-7. doi: 10.1016/j.bbrc.2014.04.122. Epub 2014 May 2.

PMID:
24796674
6.

Improvement of depression-like behavior and memory impairment with the ethanol extract of Pleurotus eryngii in ovariectomized rats.

Minami A, Matsushita H, Horii Y, Ieno D, Matsuda Y, Saito M, Kanazawa H, Ohyama Y, Wakatsuki A, Takeda A, Hidari KI, Sabaratnam V, Suzuki T.

Biol Pharm Bull. 2013;36(12):1990-5.

7.

Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells.

Hidari KI, Yamaguchi M, Ueno F, Abe T, Yoshida K, Suzuki T.

Biochem Biophys Res Commun. 2013 Jul 5;436(3):394-9. doi: 10.1016/j.bbrc.2013.05.112. Epub 2013 Jun 4.

PMID:
23747419
8.

Carbohydrate-related inhibitors of dengue virus entry.

Hidari KI, Abe T, Suzuki T.

Viruses. 2013 Feb 6;5(2):605-18. doi: 10.3390/v5020605. Review.

9.

Design and synthesis of a novel ganglioside ligand for influenza A viruses.

Nohara T, Imamura A, Yamaguchi M, Hidari KI, Suzuki T, Komori T, Ando H, Ishida H, Kiso M.

Molecules. 2012 Aug 10;17(8):9590-620. doi: 10.3390/molecules17089590.

10.

3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.

Hidari KI, Ikeda K, Watanabe I, Abe T, Sando A, Itoh Y, Tokiwa H, Morita K, Suzuki T.

Biochem Biophys Res Commun. 2012 Aug 3;424(3):573-8. doi: 10.1016/j.bbrc.2012.07.002. Epub 2012 Jul 7.

PMID:
22776202
11.

No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8).

Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Muranaka M, Ueno T, Kinoshita Y, Niwa H, Hidari KI, Suzuki T.

Acta Vet Scand. 2012 Apr 16;54:25. doi: 10.1186/1751-0147-54-25.

12.

Dengue virus receptor.

Hidari KI, Suzuki T.

Trop Med Health. 2011 Dec;39(4 Suppl):37-43. doi: 10.2149/tmh.2011-S03. Epub 2011 Aug 6.

13.

Antiviral agents targeting glycans on dengue virus E-glycoprotein.

Hidari KI, Suzuki T.

Expert Rev Anti Infect Ther. 2011 Nov;9(11):983-5. doi: 10.1586/eri.11.115.

PMID:
22029517
14.

Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus.

Chen J, Yamada S, Hama Y, Shetty AK, Kobayashi T, Oda H, Seiki K, Kim E, Kimura T, Takahashi N, Hidari KI, Suzuki T, Suzuki Y, Sugahara K.

Biochem Biophys Res Commun. 2011 Aug 19;412(1):136-42. doi: 10.1016/j.bbrc.2011.07.059. Epub 2011 Jul 22.

15.

Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells.

Wichit S, Jittmittraphap A, Hidari KI, Thaisomboonsuk B, Petmitr S, Ubol S, Aoki C, Itonori S, Morita K, Suzuki T, Suzuki Y, Jampangern W.

Microbiol Immunol. 2011 Feb;55(2):135-40. doi: 10.1111/j.1348-0421.2010.00293.x.

16.

Infectivity and pathogenicity of canine H3N8 influenza A virus in horses.

Yamanaka T, Tsujimura K, Kondo T, Matsumura T, Ishida H, Kiso M, Hidari KI, Suzuki T.

Influenza Other Respir Viruses. 2010 Nov;4(6):345-51. doi: 10.1111/j.1750-2659.2010.00157.x.

17.

[Structure and function of glycoconjugates involved in dengue virus infection].

Hidari KI, Suzuki T.

Seikagaku. 2010 Aug;82(8):751-5. Review. Japanese. No abstract available.

PMID:
20857691
18.

Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.

Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T.

Antiviral Res. 2010 Nov;88(2):236-43. doi: 10.1016/j.antiviral.2010.09.002. Epub 2010 Sep 21.

PMID:
20851716
19.

Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.

Sakamoto J, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KI, Jampangern W, Suzuki T, Suzuki Y, Esumi Y, Nakamura T, Hatano K, Terunuma D, Matsuoka K.

Bioorg Med Chem. 2009 Aug 1;17(15):5451-64. doi: 10.1016/j.bmc.2009.06.036. Epub 2009 Jun 21.

PMID:
19592257
20.

Molecular design of spacer-N-linked sialoglycopolypeptide as polymeric inhibitors against influenza virus infection.

Ogata M, Hidari KI, Kozaki W, Murata T, Hiratake J, Park EY, Suzuki T, Usui T.

Biomacromolecules. 2009 Jul 13;10(7):1894-903. doi: 10.1021/bm900300j. Epub 2009 May 13.

PMID:
19438195
21.

Identification and characterization of flavonoids as sialyltransferase inhibitors.

Hidari KI, Oyama K, Ito G, Nakayama M, Inai M, Goto S, Kanai Y, Watanabe K, Yoshida K, Furuta T, Kan T, Suzuki T.

Biochem Biophys Res Commun. 2009 May 8;382(3):609-13. doi: 10.1016/j.bbrc.2009.03.082. Epub 2009 Mar 19.

PMID:
19303395
22.

Chemoenzymatic synthesis of sialoglycopolypeptides as glycomimetics to block infection by avian and human influenza viruses.

Ogata M, Hidari KI, Murata T, Shimada S, Kozaki W, Park EY, Suzuki T, Usui T.

Bioconjug Chem. 2009 Mar 18;20(3):538-49. doi: 10.1021/bc800460p.

PMID:
19215136
23.

Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga.

Hidari KI, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T.

Biochem Biophys Res Commun. 2008 Nov 7;376(1):91-5. doi: 10.1016/j.bbrc.2008.08.100. Epub 2008 Aug 30.

PMID:
18762172
24.

Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.

Hidari KI, Murata T, Yoshida K, Takahashi Y, Minamijima YH, Miwa Y, Adachi S, Ogata M, Usui T, Suzuki Y, Suzuki T.

Glycobiology. 2008 Oct;18(10):779-88. doi: 10.1093/glycob/cwn067. Epub 2008 Jul 11.

PMID:
18621993
25.

Sulfatide is required for efficient replication of influenza A virus.

Takahashi T, Murakami K, Nagakura M, Kishita H, Watanabe S, Honke K, Ogura K, Tai T, Kawasaki K, Miyamoto D, Hidari KI, Guo CT, Suzuki Y, Suzuki T.

J Virol. 2008 Jun;82(12):5940-50. doi: 10.1128/JVI.02496-07. Epub 2008 Apr 16.

26.

Binding kinetics of influenza viruses to sialic acid-containing carbohydrates.

Hidari KI, Shimada S, Suzuki Y, Suzuki T.

Glycoconj J. 2007 Dec;24(9):583-90. Epub 2007 Jul 11.

PMID:
17624609
27.

Novel linear polymers bearing thiosialosides as pendant-type epitopes for influenza neuraminidase inhibitors.

Matsuoka K, Takita C, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KI, Jampangern W, Suzuki T, Suzuki Y, Hatano K, Terunuma D.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3826-30. Epub 2007 May 13.

PMID:
17524642
28.

The new role of disodium cromoglycate in the treatment of adults with bronchial asthma.

Miyatake A, Fujita M, Nagasaka Y, Fujita K, Tamari M, Watanabe D, Nakano N, Hidari KI, Suzuki Y.

Allergol Int. 2007 Sep;56(3):231-9. Epub 2007 Jun 1.

29.

The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors.

Guo CT, Takahashi N, Yagi H, Kato K, Takahashi T, Yi SQ, Chen Y, Ito T, Otsuki K, Kida H, Kawaoka Y, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y.

Glycobiology. 2007 Jul;17(7):713-24. Epub 2007 Mar 27.

PMID:
17389652
30.

Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols.

Collins PM, Hidari KI, Blanchard H.

Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):415-9. Epub 2007 Feb 21.

PMID:
17327679
31.

Lactotriaose-containing carbosilane dendrimers: syntheses and lectin-binding activities.

Yamada A, Hatano K, Koyama T, Matsuoka K, Takahashi N, Hidari KI, Suzuki T, Suzuki Y, Terunuma D.

Bioorg Med Chem. 2007 Feb 15;15(4):1606-14. Epub 2006 Dec 20.

PMID:
17197189
32.
33.

Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors.

Sakamoto J, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KI, Jampangern W, Suzuki T, Suzuki Y, Esumi Y, Hatano K, Terunuma D, Matsuoka K.

Bioorg Med Chem Lett. 2007 Feb 1;17(3):717-21. Epub 2006 Nov 1.

PMID:
17095224
35.

Edible bird's nest extract inhibits influenza virus infection.

Guo CT, Takahashi T, Bukawa W, Takahashi N, Yagi H, Kato K, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y.

Antiviral Res. 2006 Jul;70(3):140-6. Epub 2006 Mar 3.

PMID:
16581142
36.
37.

Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2.

Aoki C, Hidari KI, Itonori S, Yamada A, Takahashi N, Kasama T, Hasebe F, Islam MA, Hatano K, Matsuoka K, Taki T, Guo CT, Takahashi T, Sakano Y, Suzuki T, Miyamoto D, Sugita M, Terunuma D, Morita K, Suzuki Y.

J Biochem. 2006 Mar;139(3):607-14.

PMID:
16567427
38.

Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Suzuki T, Takahashi T, Guo CT, Hidari KI, Miyamoto D, Goto H, Kawaoka Y, Suzuki Y.

J Virol. 2005 Sep;79(18):11705-15.

39.

Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli.

Hidari KI, Horie N, Murata T, Miyamoto D, Suzuki T, Usui T, Suzuki Y.

Glycoconj J. 2005 Feb;22(1-2):1-11.

PMID:
15864429
40.

In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection.

Hidari KI, Tsujii E, Hiroi J, Mano E, Miyatake A, Miyamoto D, Suzuki T, Suzuki Y.

Biol Pharm Bull. 2004 Jun;27(6):825-30.

41.

Evolutional analysis of human influenza A virus N2 neuraminidase genes based on the transition of the low-pH stability of sialidase activity.

Suzuki T, Takahashi T, Saito T, Guo CT, Hidari KI, Miyamoto D, Suzuki Y.

FEBS Lett. 2004 Jan 16;557(1-3):228-32.

42.

Inhibition of influenza A virus sialidase activity by sulfatide.

Suzuki T, Takahashi T, Nishinaka D, Murakami M, Fujii S, Hidari KI, Miyamoto D, Li YT, Suzuki Y.

FEBS Lett. 2003 Oct 23;553(3):355-9.

43.

[Functional glycoconjugates involved in cellular interaction].

Hidari KI.

Yakugaku Zasshi. 2003 May;123(5):315-22. Review. Japanese.

44.

A molecular mechanism for the low-pH stability of sialidase activity of influenza A virus N2 neuraminidases.

Takahashi T, Suzuki T, Hidari KI, Miyamoto D, Suzuki Y.

FEBS Lett. 2003 May 22;543(1-3):71-5.

45.

Identification of glycosphingolipid receptors for pierisin-1, a guanine-specific ADP-ribosylating toxin from the cabbage butterfly.

Matsushima-Hibiya Y, Watanabe M, Hidari KI, Miyamoto D, Suzuki Y, Kasama T, Kasama T, Koyama K, Sugimura T, Wakabayashi K.

J Biol Chem. 2003 Mar 14;278(11):9972-8.

46.

Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses.

Totani K, Kubota T, Kuroda T, Murata T, Hidari KI, Suzuki T, Suzuki Y, Kobayashi K, Ashida H, Yamamoto K, Usui T.

Glycobiology. 2003 May;13(5):315-26. Epub 2002 Dec 17.

PMID:
12626382
47.

An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses.

Guo CT, Sun XL, Kanie O, Shortridge KF, Suzuki T, Miyamoto D, Hidari KI, Wong CH, Suzuki Y.

Glycobiology. 2002 Mar;12(3):183-90.

PMID:
11971862
48.

Duck and human pandemic influenza A viruses retain sialidase activity under low pH conditions.

Takahashi T, Suzuki Y, Nishinaka D, Kawase N, Kobayashi Y, Hidari KI, Miyamoto D, Guo CT, Shortridge KF, Suzuki T.

J Biochem. 2001 Aug;130(2):279-83.

49.

Engagement of endogenous ganglioside GM1a induces tyrosine phosphorylation involved in neuron-like differentiation of PC12 cells.

Kimura M, Hidari KI, Suzuki T, Miyamoto D, Suzuki Y.

Glycobiology. 2001 Apr;11(4):335-43.

PMID:
11358882
50.

Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains.

Guo CT, Nakagomi O, Mochizuki M, Ishida H, Kiso M, Ohta Y, Suzuki T, Miyamoto D, Hidari KI, Suzuki Y.

J Biochem. 1999 Oct;126(4):683-8.

Supplemental Content

Loading ...
Support Center